July 24, 2015
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Editor, Karl Oestreich; Assistant Editor, Carmen Zwicker The Wall Street Journal Doctors Object to High […]
Tags: “Rochester Now” smartphone app, 50 leaders in health IT, AARP, ABC15 Arizona, aging of the baby-boom generation, Akron Beacon Journal, Albert Lea Tribune, alzheimer's disease, American Pharmacists Association, American Society of Clinical Oncology, Amyotrophic Lateral Sclerosis (ALS), Arizona
June 21, 2012
Mayo Clinic in the News Weekly Highlights
June 21, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations NY […]
Tags: alzheimer's disease, American Society of Clinical Oncology, Center for Medicare and Medicaid Innovation, Chemotherapy, Chicago Tribune, Dr. James A. Levine, Dr. John Black, Dr. John Noseworthy, Esther H. Krych, Florida Times-Union, ginseng, government funding
June 8, 2012
Mayo Clinic in the News Weekly Highlights
June 8, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations Wall […]
Tags: American Society of Clinical Oncology, Chicago Sun-Times, Dr. Issam Moussa, Dr. James O'Keefe, Dr. Joseph Mikhael, Dr. Mary O'Connor, Dr. Vincent Rajkumar, Eau Claire Leader-Telegram, ESPN The Magazine, Genentech, ginseng, HealthDay
June 1, 2012
New Class of Cancer Drugs May Be Less Toxic
The experimental treatment, called T-DM1, is a harbinger of a new class of cancer drugs that may be more effective and less toxic than many existing treatments. By harnessing antibodies to deliver toxic payloads to cancer cells, while largely sparing healthy cells, the drugs are a step toward the “magic bullets” against cancer first envisioned […]
Tags: Adcetris, American Society of Clinical Oncology, Dr. Edith Perez, experimental treatment, NY Times, Paul Ehrlich, Seattle Genetics
May 24, 2012
New Multiple Myeloma Treatments On The Horizon (ASCO 2012)
During the upcoming annual meeting of the American Society of Clinical Oncology (ASCO), results will be presented from clinical trials involving potential new drugs under development for the treatment of multiple myeloma. In particular, results for newer, lesser known agents that are in the early stages of clinical development will take center stage. These agents […]
Tags: American Society of Clinical Oncology, Dr. A. K. Stewart, multiple myeloma, Myeloma Beacon